Kyowa Pharmaceutical Industry Co will set up the plant at Tottori, as part of expansion plans in the country
Lupin’s wholly-owned Japanese subsidiary, Kyowa Pharmaceutical Industry Co , plans to set up a manufacturing plant at Tottori, Japan as part of expansion plans in the country.
“In order to meet the rapidly growing demand of generics, the Kyowa board has proposed the setting-up of a two billion tablets capacity plant at Tottori, Japan which would be designed to efficiently handle mass volume products and provide flexibility in allowing easy future expansion,” Lupin said in a regulatory filing.
Kyowa Pharmaceutical Industry Co, the wholly-owned subsidiary of the the Mumbai-based firm, has a manufacturing facility at Sanda, Japan. The drug maker, however, did not disclose financial details regarding the proposed plant.
Comments are closed.